Related Experiment Videos
Cytogenetic studies in 56 cases with Ph1-positive hematologic disorders
Cancer Genetics and Cytogenetics
|February 1, 1982
Summary
Karyotype analysis in 56 patients with Ph1-positive disorders revealed the standard t(9;22) translocation in most cases. However, three patients lacked the Ph1 translocation, and three others showed variant translocations, highlighting genetic diversity in these hematologic conditions.
Area of Science:
- Hematology
- Cytogenetics
- Oncology
Background:
- The Philadelphia chromosome (Ph1) is a hallmark of chronic myeloid leukemia (CML).
- Understanding Ph1 translocation variants and their clinical associations is crucial for accurate diagnosis and treatment.
Purpose of the Study:
- To investigate the spectrum of karyotypic abnormalities in Ph1-positive hematologic disorders.
- To identify standard and variant Ph1 translocations and their correlation with clinical diagnoses.
Main Methods:
- Karyotyping of bone marrow and blood samples from 56 patients.
- Application of various banding techniques, including Q-, R-, and C-banding.
- Analysis of cytogenetic findings in relation to clinical and hematologic diagnoses.
Main Results:
- The standard t(9;22)(q34;q11) translocation was observed in 50 cases.
- Three cases showed no detectable Ph1 translocation, despite clinical suspicion.
- Three male patients exhibited variant Ph1 translocations, including complex rearrangements.
- Loss of the Y chromosome was noted in two cases with the standard Ph1 translocation.
Conclusions:
- The study confirms the prevalence of the standard t(9;22) translocation in Ph1-positive hematologic disorders.
- Variant Ph1 translocations and cases lacking the expected translocation highlight the genetic heterogeneity of these conditions.
- Cytogenetic analysis is essential for precise diagnosis and classification of hematologic malignancies.